What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news from ...

The BabySeq project was a first-of-its-kind initiative that used a randomised clinical trial format to assess the utility of genomic sequencing to identify disease risk in newborns.

An analysis of genes and proteins found in lung adenocarcinoma samples has revealed biomarkers linked to disease outcomes and new drug targets. The study also led to the identification of genetic ...

This feature explores The Role of Biologists in the Age of AI Foundational Models. Find our more in our upcomind Multi-Omics ...

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

Discover the latest Sequencing Buyer's Guide. Compare platforms, technologies, and key features to find the best solution for your research or clinical needs.

Advances in protein sequencing enable deeper insights and facilitate applications such as biomarker discovery and personalised medicine.

Analysis of proteins is not simple. Unlike DNA, there is incredible diversity in the concentration and variety of proteins created by a cell at any given moment. In our Proteomics Playbook we outline ...

At FOG Live: Single Cell and Spatial, Aridiman Pandit explored how single-cell and multi-omics can revolutionise drug target identification.

Back and bigger than ever, the Festival of Genomics & Biodata London is here to brighten those winter blues, bring on January 2025!